Skip to main content
. 2020 Jul 1;4(13):2979–2990. doi: 10.1182/bloodadvances.2018027813

Table 1.

Phenotypic details of the 6 IC with identified large VWF deletions

IC VWF:RCo, IU/dL VWF:Ag, IU/dL RCo/Ag VWFpp, IU/dL pp/Ag VWF:CB, IU/dL FVIII:C, IU/dL VWF:FVIIIB ABO blood group BS* Multimers Variant Exons deleted
P1F5III1 28 28 1.00 40 1.43 29 70 1.12 O/A 4 Normal c.221-977_532+7059del (p.Asp75_Gly178del) 4-5
P6F1II1 23 32 0.72 131 4.09 15 25 0.61 O/O 4 2A(sm) c.5621-478_5842+2440delins(18)§ (p.Phe1875_Cys1948del) 33-34
P6F10II1 28 29 0.97 58 2.00 44 65 1.06 O/A 14 Normal c.221-977_532+7059del (p.Asp75_Gly178del) 4-5
P9F3I2 11 12 0.92 57 4.75 12 17 0.99 O/A 6 2A(IIE) c.5455+279_5842+998delins(7)§ (p.Arg1819_Cys1948delinsSer) 32-34
P9F11II1|| 20 31 0.65 47 1.52 31 5 0.95 O/O 10 Normal c.56-335_220+1585del (p.Thr20_Gly74del) 3
P12F9III1 27 21 1.29 41 1.95 30 58 1.12 O/O 8 Normal c.221-977_532+7059del (p.Asp75_Gly178del) 4-5
Normal range 75-117 76-121 0.85-1.17 104-136 1.00-1.50 103-150 88-133 0.68-1.44

—, not applicable; pp/Ag, VWFpp/VWF:Ag ratio; RCo/Ag, VWF:RCo/VWF:Ag ratio.

*

A score ≥4 is indicative of excessive bleeding.23

Based on detailed analysis (P6F1II1 reclassified as VWD2A).25

IC were also heterozygous for c.2561G>A (p.Arg854Gln) in trans.

§

A detailed description of deletion is provided in supplemental Figure 4.

|

|IC were also heterozygous for c.8164C>G (p.Pro2722Ala) in cis.

Based on the analysis of healthy control individuals.19,24